High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma

ConclusionsOur findings indicate that the overexpression of GRP78/BiP is a novel predictor of favorable outcomes in patients with ATC who receive combination chemotherapy.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research